Pharmaceuticals
US FDA approves first 3D printed pill
05 Aug 2015
The US Food and Drug Administration on Monday approved the first prescription drug made through 3D printing in the US
Baxalta rejects drugmaker Shire’s approach
05 Aug 2015
India thwarts UK firm’s bid to patent compound of turmeric, pine bark and tea for treating hair loss
03 Aug 2015
Dr Reddy's Q1 net up 14% at Rs626 crore
30 Jul 2015
Firms “underinvest” in long-term cancer research: study
28 Jul 2015
Pharmaceutical firms “underinvest” in long-term research to develop new cancer-fighting drugs due to the greater time and cost required to conduct such research
Teva in $40.5-bn pact to buy Allergan's generics, ends Mylan bid
27 Jul 2015
Post-merger, Allergan will have one of the broadest product portfolios and strongest pipelines in the generics industry
Teva in talks to buy Allergan's generic-drug unit for $45 bn: report
27 Jul 2015
A deal with Allergan would indicate that Teva could be considering abandoning its plan to buy Mylan NV after the Netherlands-based company rejected its $40-billion takeover offer
Lupin buys US generics drug maker Gavis for $880 mn
23 Jul 2015
The cash-free and debt-free acquisition creates the fifth-largest portfolio of new drug filings with the US FDA, addressing a $63.8-billion market
